BioMarin Pharmaceutical Inc.
BMRN
$53.82
-$0.49-0.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.48B | 1.43B | 1.27B | 1.14B | 930.44M |
| Total Receivables | 790.27M | 855.86M | 739.18M | 660.54M | 777.55M |
| Inventory | 1.38B | 1.34B | 1.27B | 1.23B | 1.18B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 204.27M | 177.18M | 181.55M | 201.53M | 169.26M |
| Total Current Assets | 3.85B | 3.81B | 3.47B | 3.23B | 3.06B |
|
|
|||||
| Total Current Assets | 3.85B | 3.81B | 3.47B | 3.23B | 3.06B |
| Net Property, Plant & Equipment | 1.04B | 1.03B | 1.03B | 1.08B | 1.05B |
| Long-term Investments | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Total Other Intangibles | 233.11M | 239.62M | 247.35M | 327.38M | 260.92M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.78B | 1.68B | 1.70B | 1.63B | 1.72B |
| Total Assets | 7.61B | 7.46B | 7.15B | 6.99B | 6.85B |
|
|
|||||
| Total Accounts Payable | 389.67M | 310.80M | 293.75M | 235.40M | 312.32M |
| Total Accrued Expenses | 324.75M | 290.59M | 276.67M | 331.27M | 349.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.58M | 7.70M | 6.31M | 7.57M | 8.06M |
| Total Finance Division Other Current Liabilities | 76.44M | 75.16M | 51.48M | 32.74M | 45.78M |
| Total Other Current Liabilities | 76.44M | 75.16M | 51.48M | 32.74M | 45.78M |
| Total Current Liabilities | 798.44M | 684.25M | 628.21M | 606.99M | 715.66M |
|
|
|||||
| Total Current Liabilities | 798.44M | 684.25M | 628.21M | 606.99M | 715.66M |
| Long-Term Debt | 596.66M | 596.16M | 595.65M | 595.14M | 594.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 31.26M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 163.06M | 148.82M | 129.69M | 97.57M | 127.51M |
| Total Liabilities | 1.56B | 1.43B | 1.35B | 1.33B | 1.44B |
|
|
|||||
| Common Stock & APIC | 5.90B | 5.85B | 5.79B | 5.80B | 5.74B |
| Retained Earnings | 200.78M | 231.52M | -9.01M | -194.70M | -319.64M |
| Treasury Stock & Other | -45.23M | -56.24M | 7.97M | 50.43M | -7.07M |
| Total Common Equity | 6.06B | 6.03B | 5.79B | 5.66B | 5.41B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.06B | 6.03B | 5.79B | 5.66B | 5.41B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.06B | 6.03B | 5.79B | 5.66B | 5.41B |
|
|
|||||